Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Glycerin in hand cream can cause allergic skin reactions.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Early treatment helps stop hair loss in women of color.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Genomic approach finds new possible treatments for hair loss.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.